Comparison of Pharmacokinetics and Urinary Iron Excretion of Two Single Doses of Deferiprone in β-Thalassemia/Hemoglobin E Patients

Publisher： Karger

E-ISSN： 1423-0313|90|1-2|88-94

ISSN： 0031-7012

Source： Pharmacology, Vol.90, Iss.1-2, 2012-07, pp. : 88-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Combined UDP-Glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on Paracetamol Pharmacokinetics in β-Thalassemia/HbE

By  

Pharmacology, Vol. 79, Iss. 2, 2006-12 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects

By  

Pharmacology, Vol. 91, Iss. 1-2, 2012-11 ,pp. : 12-19

Karger

Access to resources Recommend Favorite

From Prenatal to Preimplantation Genetic Diagnosis of β-Thalassemia. Prevention Model in 8748 Cases: 40 Years of Single Center Experience

By Monni Giovanni   Peddes Cristina   Iuculano Ambra   Ibba Rosa Maria  

Journal of Clinical Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 35-35

MDPI

Access to resources Recommend Favorite

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin

By Chang Cara   Hu Yichun   Hogan Susan L.   Mercke Nickie   Gomez Madeleine   O’Bryant Cindy   Bowles Daniel W.   George Blessy   Wen Xia   Aleksunes Lauren M.   Joy Melanie S.  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1333-1333

MDPI

Access to resources Recommend Favorite

Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (200 and 800 mg) in Healthy Volunteers Receiving a Single Oral Dose

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-02 ,pp. : 97-107

Karger

Access to resources Recommend Favorite